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Abstract 
 
MEASURES OF EJECTION DURATION IN NORMAL WEIGHT AND OVERWEIGHT 
ADOLESCENT CHILDREN 
 
Nicholas D. Tocci 
B.S., Appalachian State University 
M.S., Appalachian State University 
 
 
Chairperson:  Marco Meucci 
 
 
 Purpose: To determine how measures of ejection duration, subendocardial 
viability ratio, and central arterial health are affected by the overweight condition in a sample 
of adolescent children. Methods: 34 sex and age-matched adolescent children were studied, 
with half of the total sample (17, 11 male, 6 female) classified as overweight (OW). In one 
laboratory visit, anthropometric measures (height, weight, body mass index), body 
composition analysis (body fat percentage), and non-invasive measures of central 
cardiovascular health, including resting heart rate (HR), aortic systolic (ASBP), diastolic 
(ADBP), mean arterial (AMAP) and pulse (APP) pressures, carotid-femoral pulse wave 
velocity (cf-PWV), ejection duration in milliseconds (EDms) and relative to the heart rate 
period (ED%), and the subendocardial viability ratio (SEVR) were performed. Results: As 
expected, OW adolescents weighed significantly more, had a higher body mass index, and a 
greater body fat percentage than normal weight (NW) adolescents. cf-PWV was significantly 
higher in OW compared to NW participants (5.1 m/s ± 0.9 m/s vs. 4.5 m/s ± 0.5 m/s 
respectively; F (1,32) = 6.558, p = 0.015, Cohen’s d = 0.88). OW adolescents also reported 
significantly higher values for ASBP (103.1 mmHg ± 11.8 mmHg vs. 95.7 mmHg ± 8.2 
mmHg respectively; F (1,32) = 4.444, p = 0.043, Cohen’s d = 0.72) and significantly lower 
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values of SEVR (114.4 % ± 25.9 % vs. 132.2 % ± 22.0 % respectively; F (1,32) = 4.663,       
p = 0.038; Cohen’s d = 0.33). Measures of EDms, ED%, HR, AMAP, ADBP and APP were 
not significantly different between groups despite a positive trend in mean values and 
moderate effect sizes for both HR and ED%. Conclusion: The overweight condition in 
adolescence is marked by unfavorable changes in cardiovascular health as measured by cf-
PWV, ASBP, and SEVR. Although significant differences were not found, our observations 
indicate that the ED% may still lend to the assessment of CVD risk in a larger sample with 
more obese adolescents.   
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Introduction 
Recognized by the World Health Organization as a major global health issue, the 
rising prevalence of obesity carries both contemporary and future consequences (Lobstein et 
al., 2004; Olshansky et al., 2005). Of particular concern is the incidence of obesity in 
childhood, which despite an attenuated rate of increase over the last decade remains a 
significant public health issue (Hales et al., 2017). Well-established as a risk factor for the 
development of cardiovascular disease (CVD), obesity is a unfavorable condition, as 
excessive adiposity increases the risk profile for co-morbid conditions including 
hypertension, type 2 diabetes, coronary artery disease, and dyslipidemia (Brown et al., 2000; 
Hubert et al., 1983). These associations are observed traditionally in obese adults, yet 
mounting evidence suggests that obesity in childhood leads to the development of the same 
risk factors for disease as adults (Freedman et al., 2007; Tu et al., 2011; Xi et al., 2017). 
Compared to their lean peers, overweight and obese children report significantly 
elevated systolic (SBP) and diastolic (DBP) blood pressures and demonstrate a serious risk of 
future obesity and hypertension with age (Brady, 2017; Ewald & Haldeman, 2016; Must & 
Strauss, 1999). In a cohort study of over 100,000 children 3-17 years old, BMI category was 
significantly associated with increases in SBP and DBP percentiles across all age-gender 
groups, and obese preadolescent children were significantly more likely to present with 
hypertension at a 3-year follow-up (Parker et al., 2016). Hypertensive children are also more 
likely to have left ventricular hypertrophy (Brady et al., 2008), greater arterial stiffening 
(Tounian et al., 2001) and advanced vascular aging (Le et al., 2010). 
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The rising incidence of childhood obesity and hypertension carries the potential to 
change conventional standards of disease progression, increasing the incidence of 
cardiovascular diseases in earlier stages of life. To combat this emerging issue, investigations 
employing non-invasive measures of cardiac function should be undertaken in order to 
identify measures with potential pre-diagnostic value in pediatrics. An approach 
recommended by the American Heart Association is the analysis of arterial pulse waveforms, 
which can estimate central arterial pressure, as well as the assessment of pulse wave velocity 
(PWV), a well-established clinical measurement of arterial stiffness (Urbina et al., 2009). 
Technologies such as Sphygmocor (AtCor Medical, Australia) are capable of measuring both 
pulse wave analysis (PWA) and PWV and have introduced clinically relevant product lines 
such as the XCEL that reduce operator-dependence by minimize the technical skill required 
(Butlin & Qasem, 2016).  
The minimally intrusive nature of PWA and PWV measurement makes these methods 
of cardiovascular assessment ideal for use in a pediatric research setting. Along with the 
established measures of central arterial pressure and stiffness, novel indicators of 
cardiovascular health and function are also measurable, the explorations into which are 
warranted to determine their pre-diagnostic value in a subclinical pediatric cohort. Of 
particular interest, is the evaluation of the ejection duration (ED). Also denoted historically 
as the left ventricular ejection time (LVET), ED is defined as the time in the cardiac cycle 
during which the left ventricle actively ejects blood through the aortic valve into circulation 
(Hassan & Turner, 1983). ED is measurable as either an absolute time, usually in 
milliseconds (EDms), or as a relative percentage of the total heart rate period (ED%). ED is 
measured non-invasively using arterial pulse wave analysis, and it is more accurately 
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assessed when central aortic waveforms are used (Lewis et al., 1977; Obata et al., 2017). The 
ED has demonstrated value as a CVD risk assessment in longitudinal studies (Biering‐
Sørensen et al., 2018; Haiden et al., 2014) and in the progression of heart failure (Garrard Jr 
et al., 1970). Previous work on ED within a pediatric population is scarce, and to date, little 
work has been performed regarding the association of adiposity to ED.  
Another measure that considers the ED in the context of aortic pressure and may be 
of clinical utility in a pediatric cohort is the subendocardial viability ratio (SEVR, also cited 
historically as the Buckberg index). Referencing the central aortic pressure waveform, the 
SEVR uses the systolic and diastolic area under the curve (AUC), identifying the diastolic 
pressure-time area as a surrogate for myocardial oxygen supply, and the systolic pressure-
time area as a surrogate for myocardial oxygen demand (Buckberg et al., 1972). The 
subsequent ratio (diastolic pressure-time area/systolic pressure-time area) generates an 
estimated myocardial supply-demand ratio. Although myocardial ischemia is not a concern 
for overweight and obese children, the SEVR can effectually be used to assess the resting 
workload of the heart, which is shown to be higher in overweight and obese individuals 
(Masuo et al., 2000). As the SEVR has been shown a clinically useful parameter in adults 
(Aslanger et al., 2017; Salvi et al., 2013; Scandale et al., 2018; Smith et al., 2012), 
explorations into pediatric cohorts are warranted. 
The purpose of this study is to determine how measures of ejection duration, SEVR 
and central arterial health are affected by the overweight condition in a sample of adolescent 
children in order to better understand the utility of these measures in the evaluation and 
prevention of cardiovascular disease. 
It is hypothesized that: 
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Hypothesis #1: Measures of ED relative to the total heart rate period will be longer in 
overweight compared to normal weight adolescents. 
Hypothesis #2: Measures of aortic pressure and PWV will be higher and the SEVR 
lower, adolescents who are overweight. 
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Methods 
Study Population 
Data collection for this study was performed as a part of the Pediatric Observational 
Study (POS), an ongoing longitudinal and cross-sectional study that has been approved by 
the Appalachian State University Institutional Review Board. We recruited healthy boys and 
girls ages 11-17 years currently unmedicated and without signs and symptoms of medical 
conditions including diabetes, heart, respiratory or renal disease. In order to investigate the 
differences between normal weight (NW) and overweight (OW) adolescents, BMI was used 
as the primary grouping variable. Using the CDC BMI-for-age percentile chart, children with 
a BMI greater than or equal to the 85th percentile of their age-and-sex-matched population 
were classified as OW and all children below the 85th percentile classified as NW. 
In the POS, data on sixty-two adolescent children had been collected. Of the dataset, 
seventeen participants (11 male, 6 female) were classified as OW by the CDC reference and 
lead to an unequal sample size between groups. In order to maintain samples of comparative 
size, and to eliminate bias during selection, each OW participant was matched with a NW 
counterpart primarily by sex and secondarily by age recorded at the time of testing. When 
multiple NW participants qualified for inclusion (e.g. three NW, 16-year-old males available 
to pair with one 16-year-old OW male), the proximity of birthday to the OW participant was 
used as the determining factor. 
Participants in this study were a multi-ethnic sample of members in the local 
community as well as from various regions of North Carolina. Participants and their parental 
guardians were required to read and sign a written informed consent to participate in 
research. All procedures alongside the benefits and risks of the study were explained to 
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participants, and their written informed consent was obtained from the parents before 
participation. All tests were conducted in the Pediatric Exercise Physiology Laboratory 
within the Department of Health and Exercise Science at Appalachian State University 
(Boone, NC, United States). The same protocol was used for all participants. 
 Anthropometrics and Body Composition 
Upon arrival at the lab, anthropometric measurements and body composition tests 
were performed. Height was measured with a wall mounted stadiometer to the nearest 0.1 
cm, and body weight was measured with a digital floor scale to the nearest 0.1 kg (SECA 
Technology, Germany). These measures were used in the calculation of BMI (BMI = weight, 
kg / height, m2). Body composition was assessed via air displacement plethysmography 
(BodPod, COSMED, Italy) using the Siri equation and with the thoracic gas volume 
estimated. Subjects were instructed to wear tight fitting clothes, wore a rubber swimmers cap, 
and did not have on shoes or jewelry prior to the measurement. Participants were instructed 
to sit with upright posture inside the BodPod chamber with feet flat on the floor, hands flat 
on their thighs and to remain still and breathe normally for the 45 – 60 second test duration. 
Two measurements of body fat percentage (%FM) were taken, and the average value was 
reported. 
Cardiovascular Measurement 
All cardiovascular measurements were obtained from the automated Sphygmocor 
XCEL (AtCor Medical, Sydney Australia), from which the tests of pulse wave analysis 
(PWA) and carotid-femoral pulse wave velocity (cf-PWV) were performed. 
Measurement of Pulse Wave Analysis 
MEASURES OF EJECTION DURATION IN ADOLESCENTS 
	
	
	
7 
In a dimly lit room, participants laid supine on a cushioned table and rested for five 
minutes while a brachial blood pressure cuff was positioned around the right arm with the 
valve positioned distally and rotated towards the medial aspect of the arm. During the PWA 
measurement, brachial blood pressure measurements were obtained, followed by a 10-second 
sample of brachial pulse waves captured by the oscillometric cuff. From the brachial 
measurements, transfer functions are applied to generate a reconstructed aortic pulse 
waveform (Butlin & Qasem, 2016). From the reconstructed aortic waveform, all measures of 
aortic systolic (ASBP), diastolic (ADBP), mean (AMAP), and pulse pressures (APP) as well 
as resting heart rate (HR), ED and SEVR were derived. The ED was defined as beginning 
with the initial upstroke of the forward wave and ending with the occurrence of the dicrotic 
notch and was reported as both EDms and ED%. The Buckberg SEVR was determined in the 
XCEL by the quotient of the diastolic pressure-time area to the systolic pressure-time area. 
The ratio was then expressed as a percentage, with values higher than 100% indicating that 
the diastolic pressure-time area was greater than the systolic. 
Measures of PWA were performed a minimum of three times with one-minute rest 
intervals and until at least two tests were within the standard allowable range (± 5 mmHg) for 
brachial systolic and diastolic pressure (Pickering et al., 2005). Quality of the pulse 
waveforms of each measurement were evaluated, with the acceptable quality control set at 
≥90%. Once determined, the two best trials for each participant were averaged and reported. 
Measurement of Pulse Wave Velocity 
Measured via applanation tonometry, cf-PWV (m/s) was calculated as the distance 
between carotid-femoral measurement sites (m) divided by the transit time of the pulse wave 
(s). Upon completion of the PWA, the participant remained supine while an oscillometric 
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cuff was positioned around the right thigh with the cuff valve positioned proximomedially to 
the thigh. Three measurements indicative of vascular distance were then made with tape 
measure (in cm): 1. Carotid artery (located via palpation) to sternal notch, 2. Sternal notch to 
the proximal end of cuff, 3. Femoral pulse to the proximal end of cuff. Each test was assessed 
for passing quality by analyzing waveform amplitude and consistency. A minimum of two 
trials were performed sequentially with additional trials added if values did not fall within the 
acceptable range of 0.3 m/s (Butlin & Qasem, 2016). The average of the two accepted 
measures was reported and included in analysis. 
Statistical Analysis 
The dependent variables obtained from anthropometrics, body composition, PWA 
and PWV assessments were grouped and analyzed using a one-way ANOVA. Assumptions 
of sphericity were verified using Levene’s test for homogeneity of variance. The Cohen’s d 
measure of effect size was also determined and reported for all measures of PWA and cf-
PWV.  Analyses were performed using SPSS Software (IBM). A priori level of significance 
was set at p ± 0.05. Results are expressed as mean ± SD. 
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Results 
Thirty-four sex and age-matched participants were included in this study. Half of the 
sample (17, 11 male & 6 female) was classified as OW with the other half (11 male & 6 
female) classified as NW. Both groups were of similar age and height, while the OW group 
reported significantly greater weight, BMI, and %FM as expected. The descriptive 
characteristics of both samples can be seen in Table 1. 
All cardiovascular measures along with their respective p-values and effect sizes are 
reported in table 2. Compared to the NW group, OW adolescents reported significantly 
higher measures of cf-PWV (F (1,32) = 6.558) and ASBP (F (1,32) = 4.444) and a 
significantly lower SEVR (F (1,32) = 4.663). Measures of ED, both in milliseconds and 
relative to the total cardiac cycle, were not significantly different between OW and NW 
children. Concurrently, resting HR, ADBP, AMAP and APP were not significantly different 
between groups.  
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Table 1 
Descriptive characteristics of participants. All data are reported mean ± SD. 
Descriptive Normal Weight 
(N=17) 
Overweight 
(N=17) 
p value 
Age (years) 14.2 ± 2.4 14.1 ± 2.3 1.000 
Height (cm) 165.3 ± 12.8 166.6 ± 11.7 0.762 
Weight (kg) 51.8 ± 10.4 82.1 ± 23.7 < 0.01 
BMI (kg/m2) 18.8 ± 2.2 29.9 ± 5.4  < 0.01 
FM (%) 17.3 ± 8.7 36.1 ± 10.3 < 0.01 
Note. BMI, body mass index; FM, fat mass. 
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Table 2  
Cardiovascular measurements of all participants split by groups. Data are reported mean ± 
SD. 
Measurement Normal Weight 
(N=17) 
Overweight 
(N = 17) 
p value Cohen’s d 
ASBP (mmHg) 95.7 ± 8.2 103.1 ± 11.8 0.043 0.72 
ADBP (mmHg) 62.7 ± 7.1 68.0 ± 10.2 0.086 0.61 
AMAP (mmHg) 75.8 ± 7.3 81.9 ± 11.5 0.075 0.63 
APP (mmHg) 33.2 ± 5.5 34.8 ± 5.9 0.421 0.28 
HR (bpm) 66.8 ± 9.1 73.2 ± 10.5 0.066 0.65 
SEVR (%) 132.2 ± 22.0 114.4 ± 25.9 0.038 0.33 
ED (%) 38.8 ± 5.4 41.7 ± 5.9 0.151 0.51 
ED (ms) 345.9 ± 19.3 345.8 ± 19.0 0.975 0.01 
cf-PWV (m/s) 4.5 ± 0.5 5.1 ± 0.9 0.015 0.88 
Note. ASBP, aortic systolic blood pressure; ADBP, aortic diastolic blood pressure; AMAP, 
aortic mean arterial pressure; APP, aortic pulse pressure; HR, resting heart rate; cf-PWV, 
carotid -femoral pulse wave velocity; SEVR, subendocardial viability ratio; ED(%), relative 
ejection duration; ED(ms), absolute ejection duration. 
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Discussion 
The purpose of this investigation was to assess if the measurement of ED, SEVR, and 
other established measures of central arterial health are measurably different in overweight 
compared to normal weight adolescents. We aimed to explore if measurements of ED and 
SEVR could lend a meaningful perspective to the prognosis of overweight children regarding 
their CV health when studied in conjunction with aortic blood pressure and cf-PWV.  
The primary finding demonstrated that cf-PWV and ASBP were higher in OW than in 
NW adolescents (table 2). Measurements of cf-PWV and PWA are accepted as valid 
measures of arterial stiffness in adults, however, they pose a greater technical challenge in 
children due to a lack of supporting validation studies and ethical concerns of performing 
invasive methodologies in healthy young populations (Savant et al., 2014; Urbina et al., 
2009). Despite this, many studies in children report a positive association between BMI and 
cf-PWV (Çelik et al., 2011; Correia-Costa et al., 2016; Dangardt et al., 2013; Sakuragi et al., 
2009; Urbina et al., 2010) as well as with ASBP (Castro et al., 2016; García-Espinosa et al., 
2016).  In a study of 84 children of similar age to our adolescent groups (10-18 years old), 
obese children reported higher values of PWV and central SBP. Amongst the obese children 
studied, those who were hypertensive (45 children) reported the highest values of Central 
SBP, PWV, and left ventricular mass as measured by echocardiography, further suggesting 
the potential for maladaptive cardiac remodeling in these individuals (Wojtowicz et al., 
2017). Our reported increases of cf-PWV and ASBP in OW children are consistent with the 
existing literature and provide further support of a relationship between the OW condition 
and the development of stiffer central arteries. This change is recognized as unfavorable, as 
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affected adolescents are likely placed at higher risk for the development of future CVD (Ayer 
et al., 2015; Cote et al., 2013). 
Concurrently, it was found that elevated values of central pressure and stiffness were 
accompanied by a significant decrease in the SEVR for OW adolescents (table 2); a 
population for which few studies have investigated the utility of the measurement. In adults, 
work by Smith and colleagues found that baseline measures of the SEVR were decreased in 
obese versus nonobese firefighters, indicating that a greater resting myocardial effort exists 
in the obese individuals and that the SEVR demonstrates clinical value worth further 
exploration as an indicator of CVD risk (Smith et al., 2012). Our findings concur with those 
observed in previous work and establish that the relationship between SEVR and excessive 
adiposity is similar in adolescence as it is in adulthood. We also recognize that SEVR values 
in OW adolescents are brought down in part by the concomitant increase in ASBP and by a 
marginal increase in the relative ED. A greater aortic systolic pressure requires an increase in 
myocardial work and is reflected by the SEVR as a larger systolic AUC. Although 
myocardial ischemia was not indicated in any of our OW adolescents, the observed changes 
in SEVR suggest a potential reduction in the myocardial perfusion, which may result in 
greater myocardial stress. This suggested reduction in perfusion is supported by adult 
research, which reports a decreased SEVR as an indication of adverse coronary perfusion in 
obese individuals (Khoshdel & Eshtiaghi, 2019). In a study of hypertensive adults with 
normal coronary arteries, SEVR was also independently related to a reduction in coronary 
blood flow reserve, a measure which was also associated with increased left ventricular mass 
(Tsiachris et al., 2012). Although little work has been performed in adolescent children, the 
findings of our study in conjunction with the existing body of adult research indicates that the 
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SEVR may be an important cardiovascular measure in overweight children and should be 
further evaluated on its utility in adolescent cohorts to predict risk of current and future CVD. 
As previously mentioned, measurements of SEVR and the ED in children have not 
been previously considered in the assessment of present and future CVD risk in children. Our 
investigation is therefore exploratory in nature, as we consider if these measures may lend 
another perspective by which the effects of pediatric obesity can be observed. Our results 
reported no difference in the ED measured in milliseconds between NW and OW 
participants. These results are unsurprising, since changes in the time of ejection and other 
systolic time intervals are considerable only in the incidence of severe cardiac remodeling 
(Weber et al., 2006; Weissler et al., 1968), which is unexpected in our nonclinical 
population.  
Because of the increased metabolic demand associated with the overweight and obese 
condition (Cote et al., 2013), a decrease in vagal tone leading to greater activity of the 
sympathetic nervous system has been reported in obese persons (Shibao et al., 2007; Tuck, 
1992). Although sympathetic activity was unable to be measured directly in this study, our 
OW group tended to report higher resting HR values than the NW group, an observation 
supported by a moderate effect size and a near-significant p-value (table 2). Although our 
results were unable to achieve statistical significance (p = 0.066), previous research has 
shown significant findings reporting higher resting HR in obese children (Urbina et al., 2010) 
and a significant relationship between BMI and resting HR in adolescent boys and girls 
(Baba et al., 2007). When HR data is combined with the observed increases in ASBP in our 
OW group, the results remain consistent with the effects of elevated sympathetic activity in 
obese persons (Kalil & Haynes, 2012)  suggesting that an elevated sympathetic activity may 
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15 
lead to an increased cardiovascular stress in overweight children. As HR increases, the 
diastolic time allotted for is subsequently reduced. Because adequate cardiac output must be 
maintained, and the ejection duration is dependent heavily on stroke volume (Braunwald et 
al., 1958; Hamada et al., 1990), the EDms remained unchanged in our participants (table 2). 
It was our hypothesis that in OW adolescents, an increased cardiovascular workload may 
augment the proportion of the heart rate period spent in systole, and characterizable by an 
increase in the ED%. The subsequent reduction in diastolic timing may contribute to a 
reduced capacity for myocardial oxygen supply via the coronary arteries, as detectable by the 
SEVR, and would indicate a subtle increase in baseline myocardial stress in overweight 
adolescents. Although ED% results were not statistically significant, the observation of a 
moderate effect size and higher mean values in the OW group indicate a positive trend in 
ED% with adiposity. In a study of almost 70 men evaluated for components of metabolic 
syndrome, significant increases in ED% were reported in subjects with metabolic syndrome 
with a difference in mean values of 2% and a standard deviation of 3% (Khoshdel & 
Eshtiaghi, 2019). Our findings in adolescents report an almost 3% difference in mean values 
of ED% with a 5% standard deviation in a much smaller sample, suggesting that significance 
may be achieved in a larger more robust sample. An a-priori power calculation based on the 
obtained results determined that a sample of 57 OW adolescents (n=117) would provide 
adequate statistical power (power = 0.85) for the measurement of ED%. The attainment of 
this larger sample remains feasible and justifies the continuation of this line of research. 
The present study demonstrates limitations that future studies should work to address. 
Although participants were matched between groups on the basis of sex and age, the 
comparison groups ultimately were not separated by sex. Also, the menstrual cycle in 
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females was not controlled for despite having potential effects on the systolic function 
(Ounis-Skali et al., 2006). As previously outlined, our study is limited by a small sample of 
OW participants in which few adolescents were identified as obese. Given that obesity 
severity is identified as an important factor in the evaluation of CVD risk (Freedman et al., 
2007), future works should emphasize the recruitment of more severely obese individuals in 
order to better elucidate the capability of non-invasive cardiovascular measures to detect 
change. 
This observational study explored the utility of the ejection duration, subendocardial 
viability ratio, and several other subclinical measures in the assessment of cardiovascular 
health in a previously unresearched sample of OW and NW children. In support of our 
second hypothesis, measures of pulse wave velocity, aortic systolic blood pressure, and 
SEVR were all negatively affected by the overweight condition in adolescents, indicating 
that these parameters demonstrate utility in the detection of cardiovascular change.	Further 
investigation of these measures is warranted to determine the extent of their clinical value in 
this cohort. In contrast to our first hypothesis, the ED% was not found significantly increased 
in our overweight group. Despite this, the observations of a higher mean value in overweight 
children and a moderate effect size indicate that the ED% may still lend to the assessment of 
CVD risk. For a better discernment of prognostic worth, a larger sample with more obese 
adolescents is warranted. Overall, the findings of this study qualify the continuation of this 
research, so that we may better understand the preventative nature of these non-invasive 
cardiovascular measurements in adolescent cohorts. 
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